Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-κB2

Journal of Experimental Medicine

Volumn 186, Issue 7, 1997, Pages 999-1014

  Ishikawa, Hideaki ^a   Carrasco, Daniel ^a   Claudio, Estefania ^a   Ryseck, Rolf Peter ^a   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CELL TYPE; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; IMMUNOPRECIPITATION; LYMPHOID HYPERPLASIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANKYRINS; BLOTTING, WESTERN; CELL DIVISION; CYTOKINES; DIMERIZATION; DNA PRIMERS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE TARGETING; HYPERPLASIA; I-KAPPA B PROTEINS; IN SITU HYBRIDIZATION; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PHENOTYPE; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RNA, MESSENGER; SEQUENCE DELETION; STOMACH; T-LYMPHOCYTES;

EID: 0030763645     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.7.999     Document Type: Article

References (67)

1. Beg, A.A., and A.S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2063-2070.
2. Gilmore, T.D., and P.J. Morin. 1993. The IκB proteins: members of a multifunctional family. Trends Genet. 9:427-433.
3. Liou, H.C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
4. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
5. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
6. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell. 80:529-532.
7. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
8. Grilli, M., J.-S. Chin, and M.J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
9. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
10. Kopp, E.B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
11. Miyamoto, S., and I.M. Verma. 1995. Rel/NF-κB/IκB story. Adv. Cancer Res. 66:255-292.
12. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development (Camb.). 118:1221-1231.
13. Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the c-rel protooncogene in hematopoietic organs. Development (Camb.). 120:2991-3004.
14. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
15. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA components of NF-κB. Nature (Lond.). 376:167-170.
16. Burkly, L., C. Hesslon, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (Lond.). 373:531-536.
17. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
18. Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
19. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hemopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
20. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell. 78:773-785.
21. Chen, Z.J., J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
22. Chen, Z.J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by novel ubiquitination-dependent protein kinase activity. Cell. 84:853-862.
23. Neri, A., C.-C. Chang, L. Lombardi, M. Salina, P. Corradini, A.T. Maiolo, R.S.K. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell. 67:1075-1087.
24. Schmid, R.M., N.D. Perkins, C.S. Duckett, P.C. Andrews, and G.J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature (Lond.). 352:733-736.
25. Bours, V., P.R. Burd, K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
26. Mercurio, F., J. DiDonato, C. Rosette, and M. Karin. 1992. Molecular cloning and characterization of a novel Rel/NF-κB family member displaying structural and functional homology to NF-κB p50/p105. DNA Cell Biol. 11:523-537.
27. Duckett, C.S., N.D. Perkins, T.F. Kowalik, R.M. Schmid, E.-S. Huang, A.S. Baldwin, Jr., and G. Nabel. 1993. Dimerization of NF-κB2 with RelA (p65) regulates DNA binding, transcriptional activation, and inhibition by an IκB-α (MAD-3). Mol. Cell. Biol. 13:1315-1322.
28. Fracchiolia, N.S., L. Lombardi, M. Slaina, A. Migliazzi, L. Baldini, E. Berti, L. Cro, E. Polli, A.T. Maiolo, and A. Neri. 1993. Structural alterations of the NF-αB transcription factor lyt-10 in lymphoid malignancies. Oncogene. 8:2839-2845.
29. Migliazza, A., L. Lombardi, M. Rocchi, D. Trecca, C.-C. Chang, R. Antonacci, N.S. Fracchiolia, P. Ciana, A.T. Maiolo, and A. Neri. 1994. Heterogeneous chromosomal aberrations generate 3′ truncations of the NFκB2/lyt-10 gene in lymphoid malignancies. Blood. 84:3850-3860.
30. McBurney, M.W., L.C. Sutherland, C.N. Adra, B. Leclair, M.A. Rudnicki, and K. Jardine. 1991. The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res. 20:5755-5761.
31. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligen. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl protooncogene. Cell. 65:1153-1163.
32. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Schevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations. In Current Protocols in Immunology. Greene Publishing Associates & Wiley-Interscience, New York. Chapter 3.
33. Schreiber, E., P. Matthias, M.M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
34. Ishikawa, H., R.-P. Ryseck, and R. Bravo. 1996. Characterization of ES cells deficient for the p105 precursor (NF-κB1): Role of p50 NLS. Oncogene. 13:255-263.
35. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel/NF-κB complexes with IκBα determine pools of constitutive and inducible NF-κB activity, which differ in their composition. EMBO (Eur. Mol. Biol. Organ.) J. 13:4608-4616.
36. Carrasco, D., C.A. Rizzo, K. Dorfman, and R. Bravo. 1996. The v-rel oncogene promotes malignant T-cell leukemia/ lymphoma in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 15:3640-3650.
37. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-bmding p50B homodimers. Cell. 72:729-739.
38. Fujita, T., G.P. Nolan, H.-C. Lion, M.L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers, Genes Dev. 7:1354-1363.
39. Modigliani, Y., G. Coutinho, O. Burlen-Defranoux, A. Coutinho, A. Bandeira. 1994. Differential contribution of thymic outputs and peripheral expansion in the development of peripheral T cell pools. Eur. J. Immunol. 24:1223-1227.
40. Mercurio, F., J. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
41. Naumann, M., A. Nieters, E.N. Hatada, and C. Scheidereit. 1993. NF-κB precursor p100 inhibits nuclear translocation and DNA binding of NF-κB/rel-factors. Oncogene. 8:2275-2281.
42. Scheinman, R.I., A.A. Beg, and A.S. Baldwin Jr. 1993. NF-κB p100 (Lyt-10) is a component of H2TF1 and can function as an IκB-like molecule. Mol. Cell. Biol. 13:6089-6101.
43. Sun, S.-C., P.A. Ganchi, C. Beraud, D.W. Ballard, and W.C. Greene. 1994. Autoregulation of the NF-κB transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc. Natl. Acad. Sci. USA. 91:1346-1350.
44. Mellits, K.H., R.T. Hay, and S. Goodbourn. 1993. Proteolytic degradation of MAD3 (IκBα) and enhanced processing of the NF-κB precursor p105 are obligatory steps in the activation of NF-κB. Nucleic Acids Res. 21:5059-5066.
45. Naumann, M., and C. Scheidereit. 1994. Activation of NF-κB in vivo is regulated by multiple phosphorylations. EMBO (Eur. Mol. Biol. Organ.) J. 13:4597-4607.
46. MacKichan, M.L., F. Logeat, and A. Israel. 1996. Phosphorylation of p105 PEST sequences via a redox-insensitive pathway up-regulates processing to p50 NF-κB. J. Biol. Chem. 271:6084-6091.
47. Thompson, J.E., R.J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:573-582.
48. Liptay, S., R.M. Schmid, E.G. Nabel, and G.J. Nabel. 1994. Transcriptional regulation of NF-κB2: evidence for κB-mediated positive and negative autoregulation. Mol. Cell. Biol. 14:7695-7703.
49. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-P.Y. Scheerlinck, and R.J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA. 93:3405-3409.
50. Thakur, S., J.-C. Lin, W.-T. Tseng, S. Kumar, R. Bravo, F. Foss, C. Gelinas, and A.B. Rabson. 1994. Rearrangement and altered expression of the NFκB-2 gene in human cutaneous T-lymphoma cells. Oncogene. 9:2335-2344.
51. Zhang, J., C.-C. Chang, L. Lombardi, and R. Dalla-Favera. 1994. Rearranged NFκB2 gene in the HUT78 T-lymphoma cell line codes for a constitutively nuclear factor lacking transcriptional represser functions. Oncogene. 9:1931-1937.
52. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFκB-2 genes in lymphoid neoplasma code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
53. Menetrier, P. 1888. Des polyadenomes gastriques et de leurs rapports avec le cancer de l'estomac. Arch. Physiol. Norm. Pathol. 1:32-55.
54. Dempsey, P.J., J.R. Goldenring, C.J. Soroka, I.M. Modlin, R.W. McClure, C.D. Lind, D.A. Ahlquist, M.R. Pittelkow, D.C. Lee, E.P. Sandgren, et al. 1992. Possible role of transforming growth factor α in the pathogenesis of Menetrier's disease: supportive evidence from humans and transgenic mice. Gastroenterology. 103:1950-1963.
55. Takagi, H., C. Jhappan, R. Sharp, and G. Merlino. 1992. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor α in the stomach. J. Clin. Invest. 96:1161-1167.
56. Bennett, C., I.M. Paterson, C.M. Corbishley, and Y.A. Luqmani. 1989. Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res. 49:2104-2111.
57. Folgueira, L., A. Algecias, W.S. MacMorran, G.D. Bren, and C.V. Paya. 1996. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and participates in the activation of NF-κB. J. Virol. 70:2332-2338.
58. Higashiyama, S., J.A. Abbraham, J. Miller, J.C. Fiddes, and M. Klagsburn. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Wash. DC). 251:936-939.
59. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
60. Bours, V., J. Villalobos, P.R. Burd, K. Kelly, and U. Siebenlist. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (Lond.). 348:76-80.
61. Bull, P., T. Hunter, and I.M. Verma. 1989. Transcriptional induction of the murine c-rel gene with serum and phorbol 12-myristrate 13-acetate in fibroblasts. Mol. Cell. Biol. 9: 5239-5243.
62. Molitor, J.A., W.H. Walker, S. Doerre, D.W. Ballard, and W.C. Greene. 1990. NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc. Natl. Acad. Sci. USA. 87:10028-10032.
63. Ryseck, R.-P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
64. Dobrzanski, P., R.-P. Ryseck, and R. Bravo. 1995. Specific inhibition of RelB/p52 transcriptional activity by the COOH-terminal domain of p100. Oncogene. 10:1003-1007.
65. Schmitz, M.L., and P.A. Baeuerle. 1991. The p65 subunit is responsible for the strong transactivating potential of NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 10:3805-3817.
66. Klement, J.F., N.R. Rice, B.D. Car, S.J. Abondanzo, G.D. Powers, H. Bhatt, C.-H. Chen, C.A. Rosen, and C.L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
67. Ghosh, S., A.M. Gifford, L.R. Riviere, P. Tempst, G.P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell. 62: 1019-1029.